Kyogo Itoh Selected Research

Antigens

08/2008	Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients.
11/2007	New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patients.
08/2007	Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancer.
07/2007	Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients.
03/2007	Identification of target antigens in specific immunotherapy for renal cell carcinoma.
03/2007	Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients.
06/2006	Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
01/2006	Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.
11/2005	Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
06/2005	Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.
06/2005	A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patients.
09/2004	Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.
09/2004	Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
08/2004	A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patients.
07/2004	Expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapy.
06/2004	Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.
06/2004	Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancer.
02/2004	T-cell receptor Vbeta gene usage by T cells reactive with the tumor-rejection antigen SART-1 in oral squamous cell carcinoma.
12/2003	Identification of two novel tumor-associated antigens recognized by HLA-B46-restricted cytotoxic T lymphocytes.
06/2003	Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
03/2002	Expression of tumor rejection antigens in colorectal carcinomas.
03/2002	Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.

Articles by Research Topic

Disease

28	Neoplasms (Cancer) 11/2007 - 02/2002
18	Prostatic Neoplasms (Prostate Cancer) 11/2007 - 07/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007 - 03/2002
4	Colonic Neoplasms (Colon Cancer) 02/2006 - 09/2004
3	Glioma (Gliomas) 08/2008 - 03/2007
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2007 - 03/2006
3	Lung Neoplasms (Lung Cancer) 06/2003 - 09/2002
2	Infection 09/2008 - 09/2007
2	Small Cell Carcinoma 09/2007 - 07/2004
2	Colorectal Neoplasms (Colorectal Cancer) 07/2007 - 03/2002
2	Hematologic Neoplasms (Hematological Malignancy) 06/2005 - 07/2004
1	Carcinoma (Carcinomatosis) 12/2006
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2006
1	Anaphylaxis (Anaphylactic Shock) 01/2006
1	Adenocarcinoma 11/2005
1	Thrombocytopenia (Thrombopenia) 08/2005
1	Breast Neoplasms (Breast Cancer) 07/2004
1	Graves Ophthalmopathy 06/2004
1	Stomach Neoplasms (Stomach Cancer) 04/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2004
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2002

Drug/Important Bio-Agent (IBA)

27	PeptidesIBA 08/2008 - 05/2002
22	AntigensIBA 08/2008 - 03/2002
4	HormonesIBA 01/2007 - 09/2003
3	AntibodiesIBA 07/2007 - 01/2004
3	HLA-A3 Antigen (HLA A3 Antigen)IBA 05/2007 - 10/2005
3	Estramustine FDA Link 01/2007 - 02/2004
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2006 - 10/2003
3	EpitopesIBA 10/2004 - 10/2003
2	Immunoglobulin E (IgE)IBA 09/2008 - 01/2006
2	Immunoglobulin G (IgG)IBA 09/2007 - 07/2007
2	KinesinIBA 03/2007 - 06/2005
2	Parathyroid Hormone-Related ProteinIBA 10/2005 - 02/2005
2	HLA-A24IBA 07/2004 - 09/2003
1	ErythropoietinIBA 08/2008
1	HLA-G antigen (HLA G)IBA 12/2007
1	PlatinumIBA 09/2007
1	Androgen Receptors (Androgen Receptor)IBA 08/2007
1	Fluorouracil (Carac)FDA LinkGeneric 07/2007
1	gemcitabine FDA Link 04/2007
1	Subunit VaccinesIBA 10/2006
1	squamous cell carcinoma-related antigenIBA 09/2006
1	prostatic acid phosphataseIBA 11/2005
1	Thrombopoietin (c-mpl Ligand)IBA 08/2005
1	Adenosine Triphosphate (ATP)IBA 05/2005
1	GTP Phosphohydrolases (GTPases)IBA 10/2004
1	Proteins (Proteins, Gene)IBA 09/2004
1	Epidermal Growth Factor Receptor (EGF Receptor)IBA 07/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2004
1	HLA-DR Antigens (HLA-DR)IBA 02/2004
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2004
1	Flutamide (Eulexin)FDA LinkGeneric 02/2004
1	human glutamate carboxypeptidase IIIBA 07/2003
1	VaccinesIBA 06/2003
1	HLA-B*4601IBA 02/2003
1	cyclophilin BIBA 09/2002
1	Cleavage And Polyadenylation Specificity FactorIBA 05/2002
1	Serine Endopeptidases (Serine Protease)IBA 02/2002

Therapy/Procedure

8	Immunotherapy 12/2007 - 03/2002
1	Drug Therapy (Chemotherapy) 09/2007
1	Prostatectomy (Retropubic Prostatectomy) 06/2007